AirSculpt Technologies, Inc. (AIRS)
$1.42-12.35%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $100M
- Beta
- 2.32
- P/E (TTM)
- -7.82
- Short % float
- 20.08%
- Days to cover
- 3.3
- SI change
- -2.1%
- 1W
- -21.98%
- 1M
- -33.33%
- vs SPY 1W
- -21.00%
- vs SPY 1M
- -35.20%
Industry peers
FMP comparable companies · ranked by market cap
- CMPSSELLCOMPASS Pathways plc$1.5BCRISISQ -4$11.47+1.17%
- AMNBUYAMN Healthcare Services, Inc.$1.4BBULLQ 21$35.44+3.07%
- INNVSELLInnovage Holding Corp.$1.2BCRISISQ 14$9.11+0.67%
- MLTXSELLMoonLake Immunotherapeutics$890MCRISISQ -1$10.58-2.59%
- SIBNBUYSI-BONE, Inc.$836MBULLQ 5$18.86-1.07%
- PACBBUYPacific Biosciences of California, Inc.$714MCRISISQ 4$2.30-2.93%
- AQSTSELLAquestive Therapeutics, Inc.$597MRECOVERYQ -4$4.76-1.28%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AIRS?
- LOPJLB’s latest quantitative signal on AirSculpt Technologies, Inc. (AIRS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AIRS in?
- AirSculpt Technologies, Inc. (AIRS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does AirSculpt Technologies, Inc. (AIRS) do?
- AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasiv…